Development of medicinal products for the treatment of post-traumatic stress disorder - Scientific guideline

This document provides guidance on the planning of clinical studies concerning the treatment of post-traumatic stress disorder.

Keywords: Post-traumatic stress disorder (PTSD), anxiety disorder

Current effective version

Guideline on the development of medicinal products for the treatment of post-traumatic stress disorder (PTSD)

Adopted Reference Number: CHMP/EWP/358650/2006 Corr 2* Legal effective date: 01/02/2009

Document history

Overview of comments received on draft guideline on the development of medicinal products for the treatment of post-traumatic stress disorder (PTSD)

Reference Number: EMEA/403001/2008 Corr*

Draft guideline on the development of medicinal products for the treatment of post-traumatic stress disorder (PTSD)

Draft: consultation closed Reference Number: CHMP/EWP/358650/06

Concept paper on the development of a guideline on the development of medicinal products for the treatment of post-traumatic stress disorder

Reference Number: EMEA/CHMP/EWP/358650/2006